期刊文献+

卵巢外腹膜癌19例误诊原因分析

An analysis of misdiagnosis of extraovarian peritoneal carcinoma in 19 cases
原文传递
导出
摘要 目的探讨卵巢外腹膜癌患者的临床误诊原因。方法回顾性分析19例卵巢外腹膜癌的临床表现、血肿瘤标志物、影像学特征、手术探查、病理学检查结果、治疗和预后。结果卵巢外腹膜癌最常见的临床表现为腹胀、腹痛和腹围增大。19例患者中,测定血中糖类抗原125(CA-125)者17例,15例升高,其中4例腹水中测得CA-125明显升高(〉10^4KU/L),12例腹水中找到癌细胞。19例患者中,有3例误诊为子宫来源肿瘤,13例误诊为附件肿瘤,1例误诊为膀胱、肠道来源肿瘤,其中仅有2例术前即诊断为腹膜肿瘤,误诊率89.47%(17/19)。术后病理结果得以证实为腹膜恶性肿瘤,5年生存率仅20%。结论无明显诱因的腹胀腹痛是本病的主要临床表现,仔细的体格检查有时可以提供重要信息,异常增高的血CA-125水平及腹水穿刺结果有助于卵巢外腹膜癌的诊断和鉴别诊断,CT对腹膜原发灶具有诊断价值。 Objective To analyze the misdiagnosis in extraovarian peritoneal carcinoma(EOPC). Methods The clinical manifestation, blood tumor marker, imaging examination, laparotomy, pathology, treatment and prognosis of 19 EOPC patients were retrospectively analyzed. Results The clinical symptoms were abdominal distention, abdominal pain and swelling. 17 cases were tested for blood CA-125 with 15 at abnormaly high level, and in 4 cases ascites was CA-125 positive ( 〉10^4 KU/L). Tumor cells were detected in the ascites in 12 cases. Three cases were misdiagnosed as of uterine origin, 13 cases misdiagnosed as adnexal tumor, 1 case was misdiagnosed as bladder and intestinal tumor. Only 2 cases were correctly diagnosed before the operation. All of the cases were pathologically proved as peritoneal carcinoma. The five-year survival rate was only 20 percent. Conclusions Abdominal distention and pain with unknown causes were the primary manifestations of EOPC, elaborate physical examination sometimes may provide with important information. The significant elevation of serum CA-125 and the ascites cytology may be helpul for the differential diagnosis of PPC. CT scan is valuable for the diagnosis of EOPC.
出处 《中华普通外科杂志》 CSCD 北大核心 2011年第7期577-579,共3页 Chinese Journal of General Surgery
关键词 腹膜肿瘤 CA-125抗原 误诊 腹水 Peritoneal neoplasms CA-125 antigen Diagnostic errors Ascites
  • 相关文献

参考文献10

  • 1MenczerJ,Chetrit A,Barda G,et al. Frequency of BRCA mutations in primary peritoneal carcinoma in Israeli Jewish women. Gynecol Oncol,2003,88 : 58-61.
  • 2Seidman JD, Zhao P, Yemelyanova A. " Primary peritoneal" high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer. Gyneeol Oneol,2010,13: 4-6.
  • 3Chi DS, Zivanovic O, Palayekar M J, et al. A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma. Gynecol Oncol, 2009, 112: 6- 10.
  • 4Choi CH, Kim TJ, Kim WY,et al. Papillary serous carcinoma in ovaries of normal size : a clinicopathologic study of 20 cases and comparison with extraovarian peritoneal papillary serous carcinoma. Gynecol Oncol,2007,105 : 762-768.
  • 5Menczer J, Chetrit A, Barda G, et al. Primary peritoneal carcinoma Uterine involvement and hysterectomy. Gynecol Onco1,2006 ,100 :565 -569.
  • 6娄越亮,王雁飞,包乐纹,张燮良.原发性腹膜癌的诊断与治疗进展[J].中国肿瘤临床,2005,32(4):236-240. 被引量:9
  • 7汪龙霞.超声诊断原发性卵巢外腹膜癌3例[J].中华超声影像学杂志,2001,10(9):573-574. 被引量:3
  • 8Wang PH, Liu RS, Li YF, et al. Whole-body PET with (fluorine-18)-2-deoxyglucose for detecting recurrent primary serous peritoneal carcinoma: an initial report. Gynecol Oncol, 2000,77 : 44-47.
  • 9Bafghi A, Zafrani Y, Pautier P, et al. Endometrial disorders in patients with peritoneal serous papillary carcinoma. Eur J Obstet Gynecol Reprod Bio!,2007,134 : 101-104.
  • 10Pentheroudakis G, Pavlidis N. Serous papillary peritoneal carcinoma: unknown primary tumour, ovarian cancer counterpart or a distinct entity? a systematic review. Crit Rev Oncol Hemato1,2010 ,75 :27-42.

二级参考文献26

  • 1张贵宇,江森,王波,王美清,王鸿云.卵巢外腹膜浆液性乳头状癌11例临床分析[J].中华妇产科杂志,1996,31(12):707-710. 被引量:24
  • 2石雪君,郭燕燕,李竞贤,汤秀英,张莹,尹玲.卵巢外腹膜浆液性乳头状癌的临床及病理学分析[J].中华妇产科杂志,1996,31(12):711-713. 被引量:22
  • 3包乐纹 陈华 等.发生于男性的腹膜癌2例[J].中国肿瘤临床,1999,:180-180.
  • 4卞度宏 叶之美 赵国英 等.原发性腹膜乳头状浆液性腺癌六例报告.中华妇产科杂志,1988,23(6):379-380.
  • 5包乐纹 陈 华 孙 莉 等.腹膜癌的MDR—1的表达.齐鲁肿瘤杂志,1999,6(2):114-114.
  • 6Attanoos RL, Webb R, Dojcinov SD, et al. Value of mesothelial and epithelial antibodies is distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcnioma of the ovary and peritoneum[]]. Histopathology, 2002, 40(3): 237-244.
  • 7Loggie BW, Fleming RA, McQuellon RP, et al. Prospective trial for the treatment of malignant peritoneal mesotheliona [J]. Am Surg, 2001, 67(10): 999-1003.
  • 8Fromm GL, Gershenson DM. Silva EG. Papillary serous carcinoma of the peritoneum[J]. Obst & Gyne, 1990, 75 (1):89-95.
  • 9Dalrymple JG, Bannatyne P, Russell P, et al. Extraovarian peritoneal serous papillery carcinoma: A clin-incopathologic study of 31 casses[J]. Cancer, 1989, 64(1):110-115.
  • 10Rothacker D, Mobius G. Varieties of serous surface papillary carcinoma of the peritoneum in northern Germany: a thirty-year autopsy study[J]. Int J Gynecol Pathol, 1995, 14(4):310-318.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部